FR2439188A1 - Composition pharmaceutique contenant des 3,4-dihydro-3-oxo-2-quinoxalines - Google Patents

Composition pharmaceutique contenant des 3,4-dihydro-3-oxo-2-quinoxalines

Info

Publication number
FR2439188A1
FR2439188A1 FR7925930A FR7925930A FR2439188A1 FR 2439188 A1 FR2439188 A1 FR 2439188A1 FR 7925930 A FR7925930 A FR 7925930A FR 7925930 A FR7925930 A FR 7925930A FR 2439188 A1 FR2439188 A1 FR 2439188A1
Authority
FR
France
Prior art keywords
dihydro
quinoxalines
oxo
pharmaceutical composition
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7925930A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of FR2439188A1 publication Critical patent/FR2439188A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
    • C07C205/12—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L'INVENTION CONCERNE DES 3,4-DIHYDRO-3-OXOQUINOXALINES PORTANT EN FONCTION ESTER EN POSITION 2 DE FORMULE: (CF DESSIN DANS BOPI) DANS LAQUELLE R ET R SONT H, NO OU CHO; R ET R SONT H, NO, CHO OU DES HALOGENES, EN RESPECTANT CERTAINES LIMITATIONS; R EST UN GROUPEMENT ALKYLE EN C-C, CYCLOALKYLE EN C-C, ALCENYLE EN C-C, UN ATOME D'HYDROGENE OU UN GROUPEMENT 2-CHLOROETHYLE; ET N VAUT 0 OU 2. CES COMPOSES SONT UTILES COMME AGENTS ANTIVIRAUX, EN PARTICULIER CONTRE LES SOUCHES MARYLAND B ET ANN ARBOR DU VIRUS DE LA GRIPPE
FR7925930A 1978-10-20 1979-10-18 Composition pharmaceutique contenant des 3,4-dihydro-3-oxo-2-quinoxalines Withdrawn FR2439188A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95315778A 1978-10-20 1978-10-20
US6044579A 1979-07-25 1979-07-25

Publications (1)

Publication Number Publication Date
FR2439188A1 true FR2439188A1 (fr) 1980-05-16

Family

ID=26739938

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7925930A Withdrawn FR2439188A1 (fr) 1978-10-20 1979-10-18 Composition pharmaceutique contenant des 3,4-dihydro-3-oxo-2-quinoxalines
FR8009368A Withdrawn FR2448899A1 (fr) 1978-10-20 1980-04-25 Utilisation therapeutique de l'acide 6,7-dichloro-3,4-dihydro-3-oxo-2-quinoxalinecarboxylique et de ses esters

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR8009368A Withdrawn FR2448899A1 (fr) 1978-10-20 1980-04-25 Utilisation therapeutique de l'acide 6,7-dichloro-3,4-dihydro-3-oxo-2-quinoxalinecarboxylique et de ses esters

Country Status (19)

Country Link
US (1) US4264600A (fr)
EP (1) EP0010426A1 (fr)
JP (1) JPS5569514A (fr)
AU (1) AU5197779A (fr)
BE (1) BE879472A (fr)
CA (1) CA1145337A (fr)
DD (1) DD146705A5 (fr)
DK (1) DK444479A (fr)
ES (2) ES485221A1 (fr)
FI (1) FI793261A (fr)
FR (2) FR2439188A1 (fr)
GB (1) GB2034302A (fr)
GR (1) GR72941B (fr)
IL (1) IL58478A0 (fr)
IT (1) IT1193847B (fr)
LU (1) LU81798A1 (fr)
PH (1) PH15791A (fr)
PT (1) PT70340A (fr)
RO (1) RO78225A (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4252954A (en) * 1979-10-25 1981-02-24 Eli Lilly And Company Salts of dihalo-3,4-dihydro-3-oxo-2-quinoxaline carboxylic acids and hindered amines
US4355030A (en) * 1980-11-14 1982-10-19 Eli Lilly And Company Antiviral combinations
JPH0678319B2 (ja) * 1986-03-11 1994-10-05 東ソー株式会社 キノキサリノン誘導体
US5037983A (en) * 1988-05-16 1991-08-06 E. R. Squibb & Sons, Inc. 6,7-dihydroxyquinoxalines as intermediates to beta-lactam antibiotics
US4904775A (en) * 1988-05-16 1990-02-27 E. R. Squibb & Sons, Inc. Heteroaroylhydrazide derivatives of monocyclic beta-lactam antibiotics
CA2024282A1 (fr) * 1989-09-21 1991-03-22 Peter H. Ermann Derives hydrazide heterocycliques de beta-lactam monocyclique antibiotique
US5169955A (en) * 1990-03-01 1992-12-08 Nippon Kayaku Kabushiki Kaisha Process for producing 2-hydroxyquinoxaline derivatives
ZA918014B (en) * 1990-11-05 1992-07-29 Squibb & Sons Inc Heteroaroyl derivatives of monocyclic beta-lactam antibiotics
WO1992011245A1 (fr) * 1990-12-20 1992-07-09 Warner-Lambert Company Derives 2-acylamido de 3,4-dihydro-3-oxo-quinoxaline possedant une activite pharmaceutique
US5250691A (en) * 1991-09-09 1993-10-05 E. R. Squibb & Sons, Inc. Heteroaryl derivatives of monocyclic beta-lactam antibiotics
TW274550B (fr) * 1992-09-26 1996-04-21 Hoechst Ag
AU744540B2 (en) * 1997-09-01 2002-02-28 Kyorin Pharmaceutical Co. Ltd. 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, addition salts thereof, and processes for the preparation of both
US8742156B2 (en) 2010-08-14 2014-06-03 British Columbia Cancer Agency Branch Anti-viral carbamimidothioic acid esters
CA2895526C (fr) * 2012-12-20 2021-08-24 Qing-bin LU Composes radiosensibilisateurs destines a etre utilises en association avec des rayonnements

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1038505A (en) * 1963-06-04 1966-08-10 Daiichi Seiyaku Co Antileprosy ointment
DE1804328A1 (de) * 1967-10-23 1969-05-22 Donau Pharmazie Gmbh 3-substituierte Chinoxalinone und Verfahren zur Herstellung von 3-substituierten Chinoxalin-2-Onen
GB1215815A (en) 1967-12-20 1970-12-16 Research Corp Production of quinoxaline-di-n-oxides and benzimidazole mono- and di-n-oxides
GB1408675A (en) 1973-03-16 1975-10-01 Allen & Hanburys Ltd Amides derived from quinoxaline
US3654275A (en) * 1969-10-15 1972-04-04 Pfizer & Co C Quinoxalinecarboxamide antiinflammatory agents
GB1308370A (en) 1969-12-09 1973-02-21 Research Corp 1-hydroxy-3-oxo-benzimidazoles quinoxaline-di-n-oxides and benzimidazole-mono-and di-n-oxides
US3962440A (en) * 1973-12-26 1976-06-08 Eli Lilly And Company Quinoxaline compounds as hypnotic agents

Also Published As

Publication number Publication date
IT7926662A0 (it) 1979-10-19
FI793261A (fi) 1980-04-21
JPS5569514A (en) 1980-05-26
ES485221A1 (es) 1980-07-01
PH15791A (en) 1983-03-25
GR72941B (fr) 1984-01-16
US4264600A (en) 1981-04-28
DD146705A5 (de) 1981-02-25
CA1145337A (fr) 1983-04-26
PT70340A (en) 1979-10-01
RO78225A (fr) 1982-02-01
BE879472A (fr) 1980-04-18
GB2034302A (en) 1980-06-04
ES485222A1 (es) 1980-09-01
FR2448899A1 (fr) 1980-09-12
IL58478A0 (en) 1980-01-31
DK444479A (da) 1980-04-21
IT1193847B (it) 1988-08-24
EP0010426A1 (fr) 1980-04-30
LU81798A1 (fr) 1980-04-21
AU5197779A (en) 1980-05-01

Similar Documents

Publication Publication Date Title
FR2439188A1 (fr) Composition pharmaceutique contenant des 3,4-dihydro-3-oxo-2-quinoxalines
GEP19960412B (en) Insecticide composition
BR8600183A (pt) Derivado de pirazolsulfonamida,processos para sua producao e composicao herbicida contendo o mesmo
BE900345A (fr) Composition pharmaceutique ophtalmiques a base d'un derive d'acide phenylacetique.
FR2436779A1 (fr) Derives de pyrrolidine-2 methanol utilisables comme medicaments
BR8105437A (pt) Processo para a preparacao de derivados de azolilaquila, composicoes fungicidas, processos para combater fungos e para a preparacao das composicoes
ZA859706B (en) Organic compounds and their pharmaceutical use
EP0103320A3 (en) Acetylsalicylic acid thioesters, a process for their preparation and pharmaceutical compositions containing them
KR890005076A (ko) 티아디아진 유도체, 그의 제조방법 및 그 화합물을 함유하는 살충제
IL65213A (en) 1,4-benzoxazine derivatives,cyclopent(b)(1,4)oxazine derivatives,their preparation and pharmaceutical compositions containing them
ES2069881T3 (es) Derivado de 15-desoxiprostaglandina.
BE905784A (fr) Carbamoyloxymethylalcoylcarbapenemes.
FR2637499A1 (fr) Medicaments a base de nouveaux derives de la methoxycarbonyl-2 n, n'-di-(trimethoxybenzoyle) piperazine
DK653687A (da) Middel til behandling af nyresygdomme
FR2395027A2 (fr) Derives de s,s'-decamethylene-1,10-mercaptan utiles comme medicaments normolipidemiants
FR2447370A1 (fr) Alkylthioalcanesulfonanilides et compositions en contenant
ES528210A0 (es) Un procedimiento para sintetizar oxanosina
KR830008480A (ko) 디니트로페놀 제초제 해독화합물을 함유한 제초제 조성물
JPS6471831A (en) Optically active chlorohydrin derivative

Legal Events

Date Code Title Description
ST Notification of lapse